Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.1B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.04B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$255M |
| 5 |
ARK Innovation ETF
ARKK
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$430M |
| 2 |
Microsoft
MSFT
|
+$365M |
| 3 |
Intel
INTC
|
+$335M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$333M |
| 5 |
Mercado Libre
MELI
|
+$309M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.43% |
| 2 | Healthcare | 5.69% |
| 3 | Financials | 4.7% |
| 4 | Consumer Discretionary | 4.61% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
PUT
General Dynamics
GD
$103B
| $3.06M | ﹤0.01% |
+13,400
| New | +$3.1M |
|
1727
WEX
WEX
$6.42B
| $3.05M | ﹤0.01% |
16,596
-1,161
| -7% | -$211K |
|
|
LSXMA
1728
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $3.05M | ﹤0.01% |
147,611
+94,033
| +176% | +$2.36M |
|
1729
CALL
Neurocrine Biosciences
NBIX
$18.2B
| $3.04M | ﹤0.01% |
+30,000
| New | +$3.12M |
|
|
1730
PUT
Neurocrine Biosciences
NBIX
$18.2B
| $3.04M | ﹤0.01% |
+30,000
| New | +$3.12M |
|
1731
Perion Network
PERI
$380M
| $3.04M | ﹤0.01% |
76,718
+33,562
| +78% | +$1.12M |
|
1732
Panagram BBB-B CLO ETF
CLOZ
$783M
| $3.02M | ﹤0.01% |
+120,000
| New | +$3.03M |
|
1733
CALL
First Citizens BancShares
FCNCA
$24.7B
| $3.02M | ﹤0.01% |
+3,100
| New | +$2.3M |
|
1734
CareDx
CDNA
$1.83B
| $3M | ﹤0.01% |
328,563
+108,809
| +50% | +$1.39M |
|
1735
Churchill Downs
CHDN
$6.17B
| $3M | ﹤0.01% |
23,334
-3,156
| -12% | -$381K |
|
1736
State Street SPDR S&P Dividend ETF
SDY
$22.1B
| $2.99M | ﹤0.01% |
24,188
+584
| +2% | +$73.5K |
|
1737
CALL
Marriott International
MAR
$100B
| $2.99M | ﹤0.01% |
+18,000
| New | +$3M |
|
1738
Emcor
EME
$29.9B
| $2.98M | ﹤0.01% |
18,335
+241
| +1% | +$37.1K |
|
1739
Axsome Therapeutics
AXSM
$11.7B
| $2.98M | ﹤0.01% |
48,322
+7,724
| +19% | +$507K |
|
1740
CALL
Cytokinetics
CYTK
$10.6B
| $2.97M | ﹤0.01% |
84,400
+54,400
| +181% | +$2.22M |
|
|
1741
PUT
Cytokinetics
CYTK
$10.6B
| $2.97M | ﹤0.01% |
84,400
+54,400
| +181% | +$2.22M |
|
1742
PUT
Norfolk Southern
NSC
$75.4B
| $2.97M | ﹤0.01% |
14,000
+8,000
| +133% | +$1.85M |
|
|
DCPH
1743
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.96M | ﹤0.01% |
191,804
+79,398
| +71% | +$1.33M |
|
1744
The Ensign Group
ENSG
$10.6B
| $2.96M | ﹤0.01% |
30,997
-10,490
| -25% | -$962K |
|
1745
CALL
Sarepta Therapeutics
SRPT
$1.64B
| $2.95M | ﹤0.01% |
21,400
+21,300
| +21,300% | +$2.76M |
|
|
KKR.PRC
1746
DELISTED
KKR & Co. Inc. 6.00% Series C Mandatory Convertible Preferred Stock
KKR.PRC
| $2.94M | ﹤0.01% |
46,413
+40,380
| +669% | +$2.62M |
|
1747
PUT
IBM
IBM
$213B
| $2.94M | ﹤0.01% |
22,400
-46,000
| -67% | -$6.15M |
|
1748
First Trust Capital Strength ETF
FTCS
$8.05B
| $2.93M | ﹤0.01% |
40,104
+446
| +1% | +$32.9K |
|
1749
ManpowerGroup
MAN
$2.6B
| $2.92M | ﹤0.01% |
35,382
-944
| -3% | -$80.4K |
|
1750
Fabrinet
FN
$14.9B
| $2.92M | ﹤0.01% |
24,578
-3,876
| -14% | -$482K |
|
Similar funds
Citigroup's Q1 2023 Portfolio in Review
As of Q1 2023, Citigroup held 6,117 positions worth $143B, up 14% from $126B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citigroup deployed $6.55B of net new capital in Q1 2023, opening 347 new positions and adding to 2,011 existing holdings. Its largest new stake was Direxion Daily S&P 500 Bull 2X ETF: 350,003 shares worth $28M.
By sector, the portfolio is most concentrated in Technology at 9.4% of assets, down from 9.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street Consumer Staples Select Sector SPDR ETF, an estimated $430M trimmed.
- Citigroup's largest Q1 2023 buy was Direxion Daily S&P 500 Bull 2X ETF: 350,003 shares worth $28M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.1B increase.
- Citigroup's biggest Q1 2023 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $430M.
- Citigroup fully exited LHC Group LLC in Q1 2023, selling an estimated $28.8M.
- Citigroup's ten largest holdings make up 34% of its $143B portfolio in Q1 2023.
- Citigroup opened 347 new positions and closed 668 in Q1 2023.
- Citigroup's portfolio value rose 14% quarter-over-quarter to $143B.
Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.